Histamine H4 receptor antagonist-1

Name: Histamine H4 receptor antagonist-1
Brand: MedChemExpress
SKU: HY-145106
Rating: 4.5 (1 reviews)

Cat. No.: HY-145106 Purity: 99.57%: FAQs
Data Sheet SDS COA Handling Instructions

Molarity Calculator

Histamine H4 receptor antagonist-1 is an antagonist of histamine H4 receptor extracted from patent WO2010108059A1 compound 60.

For research use only. We do not sell to patients.

Histamine H4 receptor antagonist-1 Chemical Structure

CAS No. : 1246207-84-0

Size	Price	Stock	Quantity
1 mg	USD 173	In-stock	Estimated Time of Arrival: December 31
5 mg	USD 432	In-stock	Estimated Time of Arrival: December 31
10 mg	USD 718	In-stock	Estimated Time of Arrival: December 31
25 mg	USD 1524	In-stock	Estimated Time of Arrival: December 31
50 mg	USD 2530	In-stock	Estimated Time of Arrival: December 31
100 mg	USD 4200	In-stock	Estimated Time of Arrival: December 31
200 mg		Get quote
500 mg		Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All Histamine Receptor Isoform Specific Products:

View All Isoforms

H₁ Receptor H₂ Receptor H₃ Receptor H₄ Receptor Histamine Receptor

Biological Activity
Purity & Documentation
References
Customer Review

Description

Histamine H4 receptor antagonist-1 is an antagonist of histamine H4 receptor extracted from patent WO2010108059A1 compound 60^[1].

IC₅₀ & Target

Histamine H4 receptor^[1]

Molecular Weight

542.68

Formula

C₃₀H₃₈N₈O₂

CAS No.

1246207-84-0

Appearance

Solid

Color

Off-white to light brown

SMILES

NC1=NC(N2CCN(CC2)C)=CC(C3=CC=C(CCN(C4)C(N[C@H](C(N(C)C)=O)CC5=CC=CC=C5)=O)C4=C3)=N1

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Solvent & Solubility

In Vitro:

DMSO : 100 mg/mL (184.27 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	1.8427 mL	9.2135 mL	18.4271 mL
5 mM	0.3685 mL	1.8427 mL	3.6854 mL
10 mM	0.1843 mL	0.9214 mL	1.8427 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (4.61 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (4.61 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Protocol 3

Add each solvent one by one: 10% DMSO 90% Corn Oil
Solubility: ≥ 2.5 mg/mL (4.61 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

DMSO +

Tween-80 +

Saline

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Calculation results:

Working solution concentration: mg/mL

Method for preparing stock solution: mg drug dissolved in μL DMSO (Stock solution concentration: mg/mL).

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).

Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.

If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.

Purity & Documentation

Purity: 99.57%

Select Batch:

Data Sheet (270 KB) SDS (252 KB)

COA (247 KB) HNMR (159 KB) RP-HPLC (226 KB) LCMS (238 KB)

Handling Instructions (2659 KB)

References

[1]. Zhou J, et, al. Substituted pyrimidine derivatives as antagonists of the histamine h4 receptor. WO2010108059A1.

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	1.8427 mL	9.2135 mL	18.4271 mL	46.0677 mL
	5 mM	0.3685 mL	1.8427 mL	3.6854 mL	9.2135 mL
	10 mM	0.1843 mL	0.9214 mL	1.8427 mL	4.6068 mL
	15 mM	0.1228 mL	0.6142 mL	1.2285 mL	3.0712 mL
	20 mM	0.0921 mL	0.4607 mL	0.9214 mL	2.3034 mL
	25 mM	0.0737 mL	0.3685 mL	0.7371 mL	1.8427 mL
	30 mM	0.0614 mL	0.3071 mL	0.6142 mL	1.5356 mL
	40 mM	0.0461 mL	0.2303 mL	0.4607 mL	1.1517 mL
	50 mM	0.0369 mL	0.1843 mL	0.3685 mL	0.9214 mL
	60 mM	0.0307 mL	0.1536 mL	0.3071 mL	0.7678 mL
	80 mM	0.0230 mL	0.1152 mL	0.2303 mL	0.5758 mL
	100 mM	0.0184 mL	0.0921 mL	0.1843 mL	0.4607 mL